Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04)-Reference-Cited by-同舟云学术

Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04)

Published:2017-12-04 Issue:3 Volume:124 Page:606-616
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Katakami Nobuyuki¹,Uchino Junji²³,Yokoyama Takuma⁴,Naito Tateaki⁵,Kondo Masashi⁶⁷,Yamada Kouzo⁸,Kitajima Hiromoto⁹,Yoshimori Kozo¹⁰,Sato Kazuhiro¹¹,Saito Hiroshi¹²,Aoe Keisuke¹³,Tsuji Tetsuya¹⁴,Takiguchi Yuichi¹⁵,Takayama Koichi²,Komura Naoyuki¹⁶,Takiguchi Toru¹⁶^ORCID,Eguchi Kenji¹⁷

Affiliation:

1. Division of Integrated Oncology, Institute of Biomedical Research and Innovation; Kobe Japan

2. Department of Pulmonary Medicine; Kyoto Prefectural University of Medicine; Kyoto Japan

3. Department of Respiratory Medicine; Fukuoka University School of Medicine; Fukuoka Japan

4. Department of Respiratory Medicine; Kyorin University Hospital; Mitaka Japan

5. Division of Thoracic Oncology; Shizuoka Cancer Center; Shizuoka Japan

6. Department of Respiratory Medicine Graduate School of Medicine; Nagoya University; Nagoya Japan

7. Department of Respiratory Medicine; Fujita Health University; Toyoake Japan

8. Department of Thoracic Oncology; Kanagawa Cancer Center; Yokohama Japan

9. Department of Respiratory Medicine; National Hospital Organization Shikoku Cancer Center; Matsuyama Japan

10. Department of Clinical Oncology, Japan Anti-Tuberculosis Association; Fukujuji Hospital; Kiyose Japan

11. Department of Respiratory Medicine; Nagaoka Red Cross Hospital; Nagaoka Japan

12. Department of Respiratory Medicine; Aichi Cancer Center Aichi Hopital; Aichi Japan

13. Department of Medical Oncology; National Hospital Organization Yamaguchi-Ube Medical Center; Ube Japan

14. Department of Rehabilitation Medicine; Keio University School of Medicine; Tokyo Japan

15. Department of Medical Oncology; Graduate School of Medicine, Chiba University; Chiba Japan

16. Ono Pharmaceutical Co, Ltd; Osaka Japan

17. Health Science on Supportive Medicine for Intractable Diseases; Teikyo University School of Medicine; Tokyo Japan

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference33 articles.

1. ABC of palliative care. Anorexia, cachexia, and nutrition;Bruera;BMJ.,1997

2. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group;Dewys;Am J Med.,1980

3. Clinical symptoms and length of survival in patients with terminal cancer;Reuben;Arch Intern Med.,1988

4. Treatment of cachexia: an overview of recent developments;Haehling;J Am Med Dir Assoc.,2014

5. Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014;Haehling;J Cachexia Sarcopenia Muscle.,2014

Cited by 175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Muscle wasting and frailty in head and neck cancer;Head and Neck Cancer Rehabilitation;2025

2. Use of anamorelin hydrochloride in a patient with lung cancer-related cachexia undergoing chemoradiotherapy: A case report;Current Problems in Cancer: Case Reports;2024-09

3. Impact of the Combination of Anamorelin and Rehabilitation on Functional and Nutritional Outcomes in Patients with Cancer Cachexia;Nutrition and Cancer;2024-08-29

4. Therapeutic potential of ghrelin/GOAT/GHSR system in gastrointestinal disorders;Frontiers in Nutrition;2024-08-23

5. Possible Extracellular Signals to Ameliorate Sarcopenia in Response to Medium-Chain Triglycerides (8:0 and 10:0) in Frail Older Adults;Nutrients;2024-08-08